A report on NBC 10 out of Massachusetts mentions a study published in the New England Journal of Medicine dealing with risks of birth control pills.
Researchers found that otherwise young, healthy women doubled their risk of heart attack and stroke if they use oral contraceptives that contain low-dose estrogen and progestin, such as the compound drospirenone.
Pregnancy itself is a risk factor for the blood clots that cause strokes. But a ...
continue reading...
A recent report on CBS’s 60 Minutes questions whether antidepressants are any more effective than placebos.
The report features an interview with Irving Kirsch, associate director of the Placebo Studies Program at Harvard Medical School, who says clinical trials simply don’t show a clinically significant advantage to antidepressants over dummy sugar pills.
“People get better when they take the drug,” Kirsch acknowledges. “But it’s not the chemical ingredients of the pills that ...
continue reading...
Fox News gives an account of a man who survived a two-and-a-half-foot blood clot stretching from his knee to his abdomen.
The report says that Gerald Cunha, 59, had swelling in his legs and pain that he attributed to sciatica. But doctors found he was suffering from deep vein thrombosis, which occurs when a clot forms in one of the body’s deep veins. According to the report, Cunha had “many classic ...
continue reading...
A stroke always occurs because of an interruption of blood flow to the brain. But a number of different underlying factors add to the risk of stroke, including recent surgery, long periods of immobility, a family history of blood clots, pregnancy and use of birth control pills.
Though most oral contraceptives can increase the risk of the blood clots that frequently cause a stroke, a number of studies indicate those containing ...
continue reading...A story in the Toledo Blade from Ohio mentions the increased risk of blood clots from Yaz and its sister drug, Yasmin.
The story points out that numerous studies indicate Yaz and Yasmin carry two-to-three times the risk of blood clots compared to other types ...
continue reading...A class action sex discrimination suit against Bayer HealthCare Pharmaceuticals has been expanded, according to a report in the Pittsburgh Post Gazette.
An amended complaint filed last month in federal court in New Jersey alleges that female sales representatives were paid less and promoted less often than their male counterparts. The amended complaint also claims women in the consumer care division were sexually harassed by Bayer executives and the company ignored ...
continue reading...
